PATENT CLAIM ANALYSIS

Application Number: 16298762
Application Type: Utility
Filing Date: 2019-03
Publication Date: 2019-07
Patent Classification: ["514", "293000"]

Abstract:
A novel class of fluorinated derivatives of Formula I have been prepared and found to be useful in the treatment of cancers and other disorders related mediated by Bromodomain-Containing Proteins.

Claim (Index 7):
The compound of  claim 1 , wherein R 1  is substituted with 1 to 5 substituent groups selected from C 1-6 alkyl, F, Cl, NO 2 , OR, R\u2032OR, CF 3 , C(\u2550O)R, NR 2 , SR, SO 2 R, S(\u2550O)R, CN, C(\u2550O)OR, C(\u2550O)NR 2 , NRC(\u2550O)R, NRC(\u2550O)OR, R\u2032NR 2 , oxo (\u2550O), imino (\u2550NR), thio (\u2550S), and oximino (\u2550N\u2014OR), wherein each R is hydrogen or a C 1-6 alkyl and R\u2032 is a C 1-6 alkylene.

Metadata:
- Claim Count in Document: 28.0
- Percentile: 99.0
- Lexical Diversity: 1.10714
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15546324', '15619671', '15749950', '14204076', '15150492']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8150204770640943
- 35 USC 102 Novelty (BERT): 0.5442627475911995
- Combined Prediction Score: 0.7879447041168048
- Mean Citation Score: 341.494826
- Max Citation Score: 400.17456
- Similarity Product: 297.0474903224945

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test